Skip to content
DraconiticResearch
Search Sources API
223,421 studies31 sourcesUpdated 38 min ago
Peer-reviewedCC BY 4.0Epidemiology and Infection

Viral interference with SARS-CoV-2 during the COVID-19 pandemic: An individual participant data meta-analysis

8 more authors
14 affiliations
  1. 1Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, The Netherlands
  2. 2Spaarne Gasthuis Academy, Spaarne Gasthuis Hoofddorp, The Netherlands
  3. 3Department of Medical Microbiology, Amsterdam UMC Locatie AMC, The Netherlands
  4. 4Department of Internal Medicine, Amsterdam UMC Locatie VUmc, The Netherlands
  5. 5Amsterdam Institute for Infection and Immunity, The Netherlands
  6. 6Department of Pediatrics, Spaarne Gasthuis, The Netherlands
  7. 7Department of Internal Medicine, Spaarne Gasthuis, The Netherlands
  8. 8National Institute for Public Health and the Environment, The Netherlands
  9. 9Regional Public Health Laboratory Kennemerland, The Netherlands
  10. 10Department of Pediatrics and Department of Neonatal and Pediatric Intensive Care, Erasmus University Medical Center Rotterdam, The Netherlands
  11. 11Department of Pediatric Infectious Diseases and Immunology, Wilhelmina Children’s Hospital, University Medical Centre Utrecht, The Netherlands
  12. 12Department of Medical Microbiology, University Medical Centre Utrecht, The Netherlands
  13. 13Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Belgium
  14. 14Department of Primary Care, Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, The Netherlands

Abstract

Viral interference between SARS-CoV-2 and other respiratory virus infections has been implicated, but symptom-based testing in observational studies may bias estimations. We used individual participant data from ten cohort studies conducted during pandemic years 2020–2024 to study virus interference. Respiratory samples were PCR-tested for viruses including SARS-CoV-2. The primary analysis was based on samples collected from cohort participants regardless of respiratory symptoms. A secondary analysis included only symptom-based testing data. We estimated odds ratios for co-occurrence of SARS-CoV-2 with other respiratory viruses. The primary analysis included data from six cohorts (n = 1 023). In total 205 of 2 465 samples were SARS-CoV-2 positive (8.3%). Co-detections with SARS-CoV-2 occurred less frequently than expected under the assumption of zero interference (OR: 0.72; 95% CI: 0.40–1.25) for samples positive for another virus. The secondary analysis (five cohorts, n = 1 715) included 2 088 samples from symptomatic subjects, with 506 SARS-CoV-2 infections (24.2%). The OR of SARS-CoV-2 detection was 0.16 (95% CI: 0.10–0.25) for samples positive for another virus. Minimizing selection bias, our results still point towards negative viral interference with SARS-CoV-2, but effect-estimates are weaker and non-significant. Apart from selection bias, the stronger effects found in symptomatic individuals could also indicate that symptomatic infection enhances virus interference.

Related

  1. High Mortality in Adults With Community-Acquired Pneumonia Admitted to Hospitals in South Africa Before and During the COVID-19 Pandemic, Stratified by HIV Serostatus and Viral Load: Data From a Prospective Cohort Study (2019–2021)
    Open forum infectious diseasesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Acute viral respiratory infections in children before and during the COVID-19 pandemic in a Peruvian reference hospital
    Jhonatan R. Mejia, Daniel Fernandez-Guzman, Medalit Luna-Vilchez +1
    Revista Peruana de Medicina Experimental y Salud PublicaPeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMC
  3. Societal values versus individual rights with respect to public health related practices during the COVID-19 pandemic in the U.S.
    Courtney Bir, Nicole Olynk Widmar, Christopher A. Wolf +2
    PLOS OnePeer-reviewedCC BY 4.0Full textEpidemiology & public healthInfectious diseasePLOS
  4. Medico-legal integration of molnupiravir rapid deployment during the COVID-19 pandemic: Emergency use authorization, clinical evidence, and risk of viral mutagenesis
    Tung-Hu Tsai
    One health (Amsterdam, Netherlands)Peer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMCEurope PMCPMC
  5. Associations between individual-level factors and adherence to social distancing measures during the COVID-19 pandemic: a global meta-analysis.
    Dewan Md Sumsuzzman, Congjie Shi, Gergely Röst +2
    BMC public healthPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMCPMC
BibTeX
@article{westrhenen2026viral,
  title = {{Viral interference with SARS-CoV-2 during the COVID-19 pandemic: An individual participant data meta-analysis}},
  author = {Emma S. E. M. Hauser-van Westrhenen and Marieke L. A. De Hoog and Angelique M. A. M. Winkel and Laia Junquera Guinovart and A. H. Ayesha Lavell and Menno D. de Jong and Marlies A. van Houten and Steven F. L. van Lelyveld and Dirk Eggink and Sjoerd Euser and Liesbeth Duijts and Joanne G. Wildenbeest and Rob Schuurman and Janneke H. H. M. van de Wijgert and Margareta Ieven and Katherine Loens and Alike W. van der Velden and Marc J. M. Bonten and Herman Goossens and Patricia C. J. L. Bruijning-Verhagen},
  journal = {Epidemiology and Infection},
  year = {2026},
  month = oct,
  doi = {10.1017/s0950268826102088},
  url = {https://doi.org/10.1017/s0950268826102088},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Viral interference with SARS-CoV-2 during the COVID-19 pandemic: An individual participant data meta-analysis
AU  - Emma S. E. M. Hauser-van Westrhenen
AU  - Marieke L. A. De Hoog
AU  - Angelique M. A. M. Winkel
AU  - Laia Junquera Guinovart
AU  - A. H. Ayesha Lavell
AU  - Menno D. de Jong
AU  - Marlies A. van Houten
AU  - Steven F. L. van Lelyveld
AU  - Dirk Eggink
AU  - Sjoerd Euser
AU  - Liesbeth Duijts
AU  - Joanne G. Wildenbeest
AU  - Rob Schuurman
AU  - Janneke H. H. M. van de Wijgert
AU  - Margareta Ieven
AU  - Katherine Loens
AU  - Alike W. van der Velden
AU  - Marc J. M. Bonten
AU  - Herman Goossens
AU  - Patricia C. J. L. Bruijning-Verhagen
PY  - 2026
DA  - 2026/10/14
JO  - Epidemiology and Infection
DO  - 10.1017/s0950268826102088
UR  - https://doi.org/10.1017/s0950268826102088
AB  - Viral interference between SARS-CoV-2 and other respiratory virus infections has been implicated, but symptom-based testing in observational studies may bias estimations. We used individual participant data from ten cohort studies conducted during pandemic years 2020–2024 to study virus interference. Respiratory samples were PCR-tested for viruses including SARS-CoV-2. The primary analysis was based on samples collected from cohort participants regardless of respiratory symptoms. A secondary analysis included only symptom-based testing data. We estimated odds ratios for co-occurrence of SARS-CoV-2 with other respiratory viruses. The primary analysis included data from six cohorts (n = 1 023). In total 205 of 2 465 samples were SARS-CoV-2 positive (8.3%). Co-detections with SARS-CoV-2 occurred less frequently than expected under the assumption of zero interference (OR: 0.72; 95% CI: 0.40–1.25) for samples positive for another virus. The secondary analysis (five cohorts, n = 1 715) included 2 088 samples from symptomatic subjects, with 506 SARS-CoV-2 infections (24.2%). The OR of SARS-CoV-2 detection was 0.16 (95% CI: 0.10–0.25) for samples positive for another virus. Minimizing selection bias, our results still point towards negative viral interference with SARS-CoV-2, but effect-estimates are weaker and non-significant. Apart from selection bias, the stronger effects found in symptomatic individuals could also indicate that symptomatic infection enhances virus interference.
SN  - 0950-2688
SN  - 1469-4409
ER  -